Characterization of the permeability barrier of human skin <i>in vivo</i>
Fabrice Pirot(NGM Biopharmaceuticals (United States)), Richard H. Guy(University of Bath), Audra L. Stinchcomb(Pharmacochimie et Biologie pour le Développement), Annette L. Bunge(Colorado School of Mines), Yogeshvar N. Kalia(University of Geneva), Garrett A. Keating(Pharmacochimie et Biologie pour le Développement)
Cited by 199
Related Papers
Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients
|Food and Chemical Toxicology|2007|1.8k
Predicting Skin Permeability
|Pharmaceutical Research|1992|1.5k
Iontophoretic drug delivery
|Advanced Drug Delivery Reviews|2003|845
Epidermal Barrier Dysfunction in Atopic Dermatitis
|Journal of Investigative Dermatology|2009|756
Transdermal drug delivery: overcoming the skin’s barrier function
|Pharmaceutical Science & Technology Today|2000|707